Transcriptomics

Dataset Information

0

NACC2 is a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease


ABSTRACT: The process of generating new neurons at the hippocampal neurogenic niche, also referred to as adult hippocampal neurogenesis (AHN), is impaired in Alzheimer’s disease (AD). MicroRNA-132 (miR-132), the most consistently downregulated microRNA (miRNA) in AD, was recently identified as a potent regulator of AHN, exerting multilayered proneurogenic effects in adult neural stem cells (NSCs) and their progeny. Supplementing miR-132 in AD mouse brain restores AHN and relevant memory deficits, yet the exact mechanisms involved are still unknown. Here, we identify NACC2 as a novel miR-132 target implicated in both AHN and AD. miR-132 deficiency in mouse hippocampus induces Nacc2 expression and inflammatory signaling in adult NSCs. We show that miR-132-dependent regulation of NACC2 is involved in the initial stages of human NSC differentiation towards astrocytes and neurons. Later, NACC2 function in astrocytic maturation becomes uncoupled from miR-132. We demonstrate that NACC2 is present in reactive astrocytes surrounding amyloid plaques in mouse and human AD hippocampus, and that there is an anticorrelation between miR-132 and NACC2 levels in AD and upon induction of inflammation. Unraveling the molecular mechanisms by which miR-132 regulates neurogenesis and cellular reactivity in AD, will provide valuable insights towards its possible application as a therapeutic target.

ORGANISM(S): Mus musculus

PROVIDER: GSE268144 | GEO | 2024/05/28

REPOSITORIES: GEO

Similar Datasets

2021-06-21 | GSE172402 | GEO
2023-05-31 | GSE230333 | GEO
2019-11-12 | PXD009845 | Pride
2023-03-08 | PXD034176 | Pride
2014-10-10 | E-GEOD-62197 | biostudies-arrayexpress
2014-03-06 | GSE55621 | GEO
2016-07-17 | E-GEOD-84481 | biostudies-arrayexpress
2014-04-05 | GSE45813 | GEO
2024-08-26 | GSE266096 | GEO
2014-10-10 | GSE62197 | GEO